中文名称: | 酒石酸卡巴拉汀 促销 | ||||
---|---|---|---|---|---|
英文名称: | Rivastigmine tartrate | ||||
别名: | 酒石酸卡巴拉汀 Exelon | ||||
CAS No: | 129101-54-8 | 分子式: | C14H22N2O2.C4H6O6 | 分子量: | 400.42 |
CAS No: | 129101-54-8 | ||||
分子式: | C14H22N2O2.C4H6O6 | ||||
分子量: | 400.42 | ||||
MDL: | MFCD03700731 |
基本信息
产品编号: |
R10001 |
||||
产品名称: |
Rivastigmine tartrate |
||||
CAS: |
129101-54-8 |
储存条件 |
粉末 |
2-8℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量 |
400.42 |
-20℃ |
1个月 |
||
化学名: |
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
50 mg/mL (124.87mM; Need ultrasonic) |
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.4974mL |
12.4869mL |
24.9738mL |
5mM |
0.4995mL |
2.4974mL |
4.9948mL |
10mM |
0.2497mL |
1.2487mL |
2.4974mL |
生物活性
产品描述 |
胆碱酯酶抑制剂,作为副交感神经或胆碱能剂。 |
|
靶点 |
IC50: 0.037μM (BChE) and 4.15μM (AChE) |
|
体外研究 |
Rivastigmine tartrate (ENA 713; 1 µM; 24 hours) reduces LPS (2.5 µg/ml)-induced TNF-α and IL-6 by 50% and 46% combined with carbachol (10 µM), respectively and does not cause any significant reduction in pro-inflammatory cytokines . Rivastigmine tartrate (1 µM), carbachol (10 µM), or a combination of both drugs, does not have a cytotoxic effect on activated cells. |
|
体内研究 |
Rivastigmine tartrate (ENA 713; 0.5-2.5 mg/kg; IP; 60 min before the tests) significantly and dose-dependently improved the behavioral impairments caused by Aluminum (HY-B1521). Rivastigmine (0.5, 1 mg/kg/day; s.c; for 8 days) reduces by about 50% and 60% respectively, the concentration of IL-6 but not those of TNF-α and IL-1β in BALB/c OlaHsd male mice aged 8-9 weeks weighing 200–250 g with acute colitis. Rivastigmine (1 mg/kg), but not (0.5 mg/kg), partially antagonized colon shrinkage and completely prevented bleeding. Treatment with rivastigmine (0.5 mg/kg) causes little change in these pathological manifestations, but rivastigmine (1 mg/kg) causes a partial restoration of the structure of the crypts and a reduction in sub-mucosal edema and cell infiltration. Rivastigmine (1 mg/kg) causes a 4.7% reduction in body weight at the end of the experiment. |
|
Animal Model: |
Male Wistar albino rats weighing 190–240 g (90 days old) |
|
Dosage: |
0.5, 1, 1.5 and 2.5 mg/kg |
|
Administration: |
IP; single dose |
|
Result: |
Significantly and dose-dependently improved the behavioral impairments caused by Aluminum (100 mg/kg/day; i.p.; for 60 days) |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )